Moderna says next generation COVID vaccine meets trial goal
Jun 15, 2024
Washington [US], June 15: Moderna (MRNA.O), opens new tab said on Thursday its next-generation COVID-19 vaccine candidate showed it was not inferior in efficacy compared to its approved shot in a late-stage study.